Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An analgesic role for cannabinoids.

C W Vaughan1, M J Christie

  • 1Department of Pharmacology, University of Sydney, NSW. chrisv@pharmacol.usyd.edu.au

The Medical Journal of Australia
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.

Nature communications·2019
Same author

Themed section.

British journal of pharmacology·2014
Same author

Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.

British journal of pharmacology·2014
Same author

β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

British journal of pharmacology·2014
Same author

Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

British journal of pharmacology·2013
Same author

Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively.

Neuropharmacology·2012
Same journal

Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

The Medical journal of Australia·2026
Same journal

Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

The Medical journal of Australia·2026
Same journal

Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

The Medical journal of Australia·2026
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
See all related articles

Cannabinoids show promise for chronic pain relief, but human studies are limited. Further research into synthetic cannabinoids and delivery systems is needed to target pain effectively without side effects.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Cannabinoids demonstrate potent analgesic effects in preclinical models, especially for chronic pain.
  • The discovery of the endogenous cannabinoid system provides a target for therapeutic development.
  • Existing cannabis-based treatments are limited by side effects, necessitating alternative approaches.

Purpose of the Study:

  • To review the analgesic potential of cannabinoids for chronic pain.
  • To explore the role of the endogenous cannabinoid system in pain modulation.
  • To discuss the development of synthetic cannabinoids for targeted pain relief.

Main Methods:

  • Literature review of preclinical and clinical studies on cannabinoid analgesia.
  • Analysis of the endogenous cannabinoid system's components and functions.

Related Experiment Videos

  • Evaluation of synthetic cannabinoid research for chronic pain applications.

    • Main Results:

    • Animal models show significant analgesic properties of cannabinoids in chronic pain.
    • The endogenous cannabinoid system offers a promising therapeutic target.
    • Synthetic cannabinoids present an opportunity to mitigate side effects associated with cannabis.

    Conclusions:

    • Cannabinoids hold significant therapeutic potential for managing chronic pain.
    • Targeted development of synthetic cannabinoids and delivery systems is crucial.
    • Well-controlled clinical trials are essential to validate efficacy and safety in humans.